|
1
|
Khoobchandani M, Ganesh N, Gabbanini S,
Valgimigli L and Srivastava MM: Phytochemical potential of Eruca
sativa for inhibition of melanoma tumor growth. Fitoterapia.
82:647–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu B, Wang Y, Yu X, Zhang H, Zhu J, Wang
C, Chen F, Liu C, Wang J and Zhu H: Cuprous oxide
nanoparticle-inhibited melanoma progress by targeting melanoma stem
cells. Int J Nanomedicine. 12:2553–2567. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma C and Armstrong AW: Severe adverse
events from the treatment of advanced melanoma: A systematic review
of severe side effects associated with ipilimumab, vemurafenib,
interferon alfa-2b, dacarbazine and interleukin-2. J Dermatolog
Treat. 25:401–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SG and Chae YS: New systemic treatment
for malignant melanoma. Korean J Intern Med (Korean Assoc Intern
Med). 85:357–363. 2013.PubMed/NCBI
|
|
7
|
Baharara J, Amini E, Nikdel N and
Salek-Abdollahi F: The cytotoxicity of dacarbazine potentiated by
sea cucumber saponin in resistant B16F10 melanoma cells through
apoptosis induction. Avicenna J Med Biotechnol. 8:112–119.
2016.PubMed/NCBI
|
|
8
|
Mongolsuk S, Robertson A and Towers R: 2:
4: 3: 5-Tetrahydroxystilbene from Artocarpus lakoocha. J
Chem Soc. 429:2231–2233. 1957. View Article : Google Scholar
|
|
9
|
Tan Y, Liu C and Chen R: Phenolic
constituents from stem bark of Morus wittiorum and their
anti-inflammation and cytotoxicity. Zhongguo Zhongyao Zazhi.
35:2700–2703. 2010.(In Chinese). PubMed/NCBI
|
|
10
|
Choi SM, Kim DH, Chun KS and Choi JS:
Carnosol induces apoptotic cell death through ROS-dependent
inactivation of STAT3 in human melanoma G361 cells. Appl Biol Chem.
62:1–11. 2019. View Article : Google Scholar
|
|
11
|
Kim YM, Yun J, Lee C-K, Lee H, Min KR and
Kim Y: Oxyresveratrol and hydroxystilbene compounds. Inhibitory
effect on tyrosinase and mechanism of action. J Biol Chem.
277:16340–16344. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chung KO, Kim BY, Lee MH, Kim YR, Chung
HY, Park JH and Moon JO: In-vitro and in-vivo anti-inflammatory
effect of oxyresveratrol from Morus alba L. J Pharm Pharmacol.
55:1695–1700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu F, Komatsu K, Saito K, Kawasaki K, Yao
X and Kano Y; Pharmacokinetic study of mulberroside A and its
metabolites in rat, : Pharmacological properties of traditional
medicines. XXII. Pharmacokinetic study of mulberroside A and its
metabolites in rat. Biol Pharm Bull. 19:1463–1467. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim J, Cho N, Kim EM, Park KS, Kang YW,
Nam JH, Nam MS and Kim KK: Cudrania tricuspidata leaf
extracts and its components, chlorogenic acid, kaempferol, and
quercetin, increase claudin 1 expression in human keratinocytes,
enhancing intercellular tight junction capacity. Appl Biol Chem.
63:1–9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McDermott DF, Mier JW, Lawrence DP, van
den Brink MR, Clancy MA, Rubin KM and Atkins MB: A phase II pilot
trial of concurrent biochemotherapy with cisplatin, vinblastine,
dacarbazine, interleukin 2, and interferon α-2B in patients with
metastatic melanoma. Clin Cancer Res. 6:2201–2208. 2000.PubMed/NCBI
|
|
16
|
Cocconi G, Bella M, Calabresi F, Tonato M,
Canaletti R, Boni C, Buzzi F, Ceci G, Corgna E, Costa P, et al:
Treatment of metastatic malignant melanoma with dacarbazine plus
tamoxifen. N Engl J Med. 327:516–523. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bedikian AY, Millward M, Pehamberger H,
Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey
P, et al Oblimersen Melanoma Study Group, : Bcl-2 antisense
(oblimersen sodium) plus dacarbazine in patients with advanced
melanoma: The Oblimersen Melanoma Study Group. J Clin Oncol.
24:4738–4745. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen H-M, Muramoto K, Yamauchi F, Fujimoto
K and Nokihara K: Antioxidative properties of histidine-containing
peptides designed from peptide fragments found in the digests of a
soybean protein. J Agric Food Chem. 46:49–53. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Monzani E, Facchetti F, Galmozzi E,
Corsini E, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D,
Santinami M, et al: Melanoma contains CD133 and ABCG2 positive
cells with enhanced tumourigenic potential. Eur J Cancer.
43:935–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Utikal J, Leiter U, Udart M, Kaskel P,
Peter RU and Krähn GM: Expression of c-myc and bcl-2 in primary and
advanced cutaneous melanoma. Cancer Invest. 20:914–921. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi HJ, Yee S-B, Park SE, Im E, Jung JH,
Chung HY, Choi YH and Kim ND: Petrotetrayndiol A induces cell cycle
arrest and apoptosis in SK-MEL-2 human melanoma cells through
cytochrome c-mediated activation of caspases. Cancer Lett.
232:214–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shanehbandi D, Zarredar H, Asadi M, Zafari
V, Esmaeili S, Seyedrezazadeh E, Soleimani Z, Jadid HS, Eyvazi S,
Feyziniya S, et al: Anticancer impacts of Terminalia catappa
extract on SW480 colorectal neoplasm cell line. J Gastrointest
Cancer. 50:1–7. 2019.
|
|
23
|
Orangi M, Pasdaran A, Shanehbandi D,
Kazemi T, Yousefi B, Hosseini BA and Baradaran B: Kazemi T, Yousefi
B, Hosseini BA and Baradran B: Cytotoxic and apoptotic activities
of methanolic subfractions of Scrophularia oxysepala against
human breast cancer cell line. Evid Based Complement Alternat Med.
2016:85406402016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu X, Liu Y, Wang L, He J, Zhang H, Chen
X, Li Y, Yang J and Tao J: Gambogic acid induces apoptosis by
regulating the expression of Bax and Bcl-2 and enhancing caspase-3
activity in human malignant melanoma A375 cells. Int J Dermatol.
48:186–192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yadav V, Varshney P, Sultana S, Yadav J
and Saini N: Moxifloxacin and ciprofloxacin induces S-phase arrest
and augments apoptotic effects of cisplatin in human pancreatic
cancer cells via ERK activation. BMC Cancer. 15:5812015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu S, Zheng Z, Zhang X, Chen F and Wang M:
Oxyresveratrol and trans-dihydromorin from the twigs of Cudrania
tricuspidata as hypopigmenting agents against melanogenesis. J
Funct Foods. 13:375–383. 2015. View Article : Google Scholar
|
|
28
|
Hu S, Chen F and Wang M: Photoprotective
effects of oxyresveratrol and Kuwanon O on DNA damage induced by
UVA in human epidermal keratinocytes. Chem Res Toxicol. 28:541–548.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bougatef A, Hajji M, Balti R, Lassoued I,
Triki-Ellouz Y and Nasri M: Antioxidant and free radical-scavenging
activities of smooth hound (Mustelus mustelus) muscle
protein hydrolysates obtained by gastrointestinal proteases. Food
Chem. 114:1198–1205. 2009. View Article : Google Scholar
|
|
30
|
Lim YH, Kim KH and Kim JK: Source,
biosynthesis, biological activities and pharmacokinetics of
oxyresveratrol. Korean J Food Sci Technol. 47:545–555. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Strassmann G, Masui Y, Chizzonite R and
Fong M: Mechanisms of experimental cancer cachexia. Local
involvement of IL-1 in colon-26 tumor. J Immunol. 150:2341–2345.
1993.PubMed/NCBI
|
|
32
|
Takagi N, Mihara M, Moriya Y, Nishimoto N,
Yoshizaki K, Kishimoto T, Takeda Y and Ohsugi Y: Blockage of
interleukin-6 receptor ameliorates joint disease in murine
collagen-induced arthritis. Arthritis Rheum. 41:2117–2121. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang XG, Bataille R, Jourdan M, Saeland
S, Banchereau J, Mannoni P and Klein B: Granulocyte-macrophage
colony-stimulating factor synergizes with interleukin-6 in
supporting the proliferation of human myeloma cells. Blood.
76:2599–2605. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee AK, Sung SH, Kim YC and Kim SG:
Inhibition of lipopolysaccharide-inducible nitric oxide synthase,
TNF-α and COX-2 expression by sauchinone effects on I-kappaBalpha
phosphorylation, C/EBP and AP-1 activation. Br J Pharmacol.
139:11–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi EM and Hwang JK: Effects of Morus
alba leaf extract on the production of nitric oxide, prostaglandin
E2 and cytokines in RAW264.7 macrophages. Fitoterapia. 76:608–613.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Naserian M, Ramazani E, Iranshahi M and
Tayarani-Najaran Z: The role of SAPK/JNK pathway in the synergistic
effects of metformin and dacarbazine on apoptosis in Raji and Ramos
lymphoma cells. Curr Mol Pharmacol. 11:336–342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pitot HC and Sirica AE: The stages of
initiation and promotion in hepatocarcinogenesis. Biochim Biophys
Acta. 605:191–215. 1980.PubMed/NCBI
|
|
38
|
Koprowska K, Hartman ML, Sztiller-Sikorska
M and Czyz ME: Parthenolide enhances dacarbazine activity against
melanoma cells. Anticancer Drugs. 24:835–845. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Prall OW, Sarcevic B, Musgrove EA, Watts
CK and Sutherland RL: Estrogen-induced activation of Cdk4 and Cdk2
during G1-S phase progression is accompanied by increased cyclin D1
expression and decreased cyclin-dependent kinase inhibitor
association with cyclin E-Cdk2. J Biol Chem. 272:10882–10894. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sheen J-H and Dickson RB: Overexpression
of c-Myc alters G(1)/S arrest following ionizing radiation. Mol
Cell Biol. 22:1819–1833. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao WX, Wu ZM, Liu W and Lin JH: Notch2
and Notch3 suppress the proliferation and mediate invasion of
trophoblast cell lines. Biol Open. 6:1123–1129. 2017.PubMed/NCBI
|
|
42
|
Rahman MA, Bishayee K, Sadra A and Huh SO:
Oxyresveratrol activates parallel apoptotic and autophagic cell
death pathways in neuroblastoma cells. Biochim Biophys Acta, Gen
Subj. 1861:23–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lorenz P, Roychowdhury S, Engelmann M,
Wolf G and Horn TF: Oxyresveratrol and resveratrol are potent
antioxidants and free radical scavengers: Effect on nitrosative and
oxidative stress derived from microglial cells. Nitric Oxide.
9:64–76. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim SH and Chung SH: Comparison of high
dose interferon-α2b immunotherapy and dacarbazine chemotherapy as
postoperative treatment of malignant melanoma. J Korean Orthop
Assoc. 51:426–431. 2016. View Article : Google Scholar
|
